Sen. Rubio Responds on Military Aid to Ukraine U.S. Senator Marco Rubio (R-FL) April 28, 2024 Wall Street Journal …Nearly nine million people have entered this country illegally since Joe Biden became president. For some Americans…, this is cause for celebration. But...
News
Latest News
Photos: Rubio Meets with Families of Hostages Held by Hamas Terrorists
U.S. Senate Select Committee on Intelligence Vice Chairman Marco Rubio (R-FL) traveled to Tel Aviv on an official visit following Iran’s unjustified attack against Israel and met with families of the hostages detained by Hamas terrorists for 205 days. “I met with the...
ICYMI: Rubio Joins I24 News
U.S. Senator Marco Rubio (R-FL) joined i24News in Israel to discuss his meeting with Prime Minister Netanyahu, Iran’s role in the present conflict, the growing antisemitic movement in the U.S., and more. See below for highlights and watch the full interview here. On...
Next Week: Rubio Staff Hosts Mobile Office Hours
U.S. Senator Marco Rubio’s (R-FL) office will host in-person Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of Senator Rubio’s...
Photos: Rubio Meets With Israeli Defense Minister Yoav Gallant
U.S. Senate Select Committee on Intelligence Vice Chairman Marco Rubio (R-FL) met today with Israeli Defense Minister Yoav Gallant to discuss the security situation in Israel and expressed his strong support for Israel’s right to defend itself. Want more...
PHOTOS: Rubio Meets with Israeli Prime Minister Benjamin Netanyahu
U.S. Senate Select Committee on Intelligence Vice Chairman Marco Rubio (R-FL) traveled to Israel on an official visit this week to meet with senior Israeli officials, conduct U.S. intelligence community oversight, and stand in solidarity with America’s closest ally in...
Rubio, Warren Introduce Bill to Address U.S. Overreliance on Foreign Pharmaceuticals
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Elizabeth Warren (D-MA) introduced the Strengthening Supply Chains for Servicemembers and Security Act to address the national security risk posed by the United States’ reliance on foreign entities for pharmaceuticals. The legislation follows a September 2021 report from the Department of Defense (DoD) Office of Inspector General (OIG) that confirmed the DoD is over-reliant on foreign made pharmaceuticals without sufficient strategies to address domestic supply chain dysfunction. The Senators successfully secured language in the National Defense Authorization Act for Fiscal Year 2021 to require an industrial capacity vulnerability study of the DoD’s dependence on foreign-made pharmaceuticals.
“The report from the Department of Defense Office of Inspector General only confirms what was made glaringly obvious during the COVID-19 pandemic: the United States remains dangerously reliant on foreign nations for its pharmaceuticals,” Rubio said. “It is unacceptable that we do not currently have a plan in place to address these supply chain issues. I’m proud to introduce this legislation to ensure that the DoD is able to reduce its reliance on nations like China for its critical pharmaceutical needs.”
“The COVID-19 pandemic has demonstrated the vulnerability of our nation’s supply chains, including of pharmaceutical products,” Warren said. “This poses a risk not only to public health but to our national security. I’m glad to lead this bill with Senator Rubio to ensure DoD takes steps to reduce its reliance on pharmaceuticals manufactured abroad and to strengthen its supply chains,” said Senator Warren.
The Strengthening Supply Chains for Servicemembers and Security Act would codify the six recommendations included in the DoD OIG report to address supply chain weaknesses:
Recommendation that the Under Secretary of Defense for Acquisition and Sustainment:
- Develop and issue implementing guidance for DoD supply chain risk management for DoD material, which includes pharmaceuticals.
- Pursue Federal legislation requiring pharmaceutical manufacturers to include APIs and final drug product country of origin information of the pharmaceuticals’ lot on the pharmaceuticals’ packaging. Specifically, the legislation would require a further review of information gaps to address reliance concerns.
Recommendation that the Director of the Defense Health Agency:
- Develop and publish implementing guidance for supply chain risk management specifically for pharmaceuticals.
- Create a chartered work group to assess risks to the pharmaceutical supply chain, identify the pharmaceuticals most critical to beneficiary care at DoD MTFs, and establish policy for allocating scarce pharmaceutical resources in case of a supply disruption.
Recommendation that the Director of the Defense Logistics Agency modify DLA Instructions 5025.03 and 3110.01 to:
- Require DLA Troop Support to coordinate annually with Military Service customers to conduct responsiveness testing of the DLA’s contingency contracts for pharmaceuticals.
- Include the contract responsiveness testing results, as reported by the Military Service customers, in the Warstopper Program annual reports.